Hugo surgical robot behind schedule Medtronic

Hugo received CE mark approval last month. Medtronic is gearing up to conduct its FDA investigational device exemption (IDE) clinical trials in the U.S. Johnson & Johnson announced its Ottava surgical robotic system will be delayed by two years due to technical development and supply-chain issues.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

54FansLike
9FollowersFollow
7SubscribersSubscribe

Latest Articles